Immunology's Coming Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alfred Nobel
www.bibalex.org/bioalex2004conf The BioVisionAlexandria 2004 Conference Newsletter November 2003 Volume 1, Issue 2 BioVisionAlexandria ALFRED NOBEL 2004 aims to celebrate the The inventor, the industrialist outstanding scientists and scholars, in a he Nobel Prize is one of the highest distinctions recognized, granting its winner century dominated by instant fame. However, many do not know the interesting history and background technological and T that led to this award. scientific revolutions, through its It all began with a chemist, known as Alfred Nobel, born in Stockholm, Sweden in 1833. Nobel Day on 3 April Alfred Nobel moved to Russia when he was eight, where his father, Immanuel Nobel, 2004! started a successful mechanical workshop. He provided equipment for the Russian Army and designed naval mines, which effectively prevented the British Royal Navy from moving within firing range of St. Petersburg during the Crimean War. Immanuel Nobel was also a pioneer in the manufacture of arms, and in designing steam engines. INSIDE Scientific awards .........3 Immanuel’s success enabled him to Alfred met Ascanio Sobrero, the Italian Confirmed laureates ....4 Lady laureates ............7 provide his four sons with an excellent chemist who had invented Nitroglycerine education in natural sciences, languages three years earlier. Nitroglycerine, a and literature. Alfred, at an early age, highly explosive liquid, was produced by acquired extensive literary knowledge, mixing glycerine with sulfuric and nitric mastering many foreign languages. His acid. It was an invention that triggered a Nobel Day is interest in science, especially chemistry, fascination in the young scientist for many dedicated to many of was also apparent. -
FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub Ã
Ranking Instituciones No Académicas por sub área OCDE 2020 3. Ciencias Médicas y de la Salud > 3.02 Medicina Clínica PAÍS INSTITUCIÓN RANKING PUNTAJE USA VA Boston Healthcare System 1 5,000 FRANCE Assistance Publique Hopitaux Paris (APHP) 2 5,000 USA UTMD Anderson Cancer Center 3 5,000 USA Mayo Clinic 4 5,000 USA Memorial Sloan Kettering Cancer Center 5 5,000 USA Dana-Farber Cancer Institute 6 5,000 USA Massachusetts General Hospital 7 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 8 5,000 USA National Institutes of Health (NIH) - USA 9 5,000 FRANCE UNICANCER 10 5,000 USA Harvard School of Dental Medicine 11 5,000 CANADA University Health Network Toronto 12 5,000 USA Cleveland Clinic Foundation 13 5,000 USA Johns Hopkins Medicine 14 5,000 FRANCE Gustave Roussy 15 5,000 NETHERLANDS Erasmus University Medical Center 16 5,000 GERMANY Helmholtz Association 17 5,000 NETHERLANDS Academic Medical Center Amsterdam 18 5,000 SPAIN CIBER - Centro de Investigacion Biomedica en Red 19 5,000 USA Beth Israel Deaconess Medical Center 20 5,000 SWITZERLAND Roche Holding 21 5,000 CANADA Princess Margaret Cancer Centre 22 5,000 USA H Lee Moffitt Cancer Center & Research Institute 23 5,000 SPAIN Hospital Universitari Vall d'Hebron 24 5,000 BELGIUM University Hospital Leuven 25 5,000 USA NIH National Cancer Institute (NCI) 26 5,000 SPAIN Hospital Clinic de Barcelona 27 5,000 USA Bristol-Myers Squibb 28 5,000 USA Merck & Company 29 5,000 UNITED KINGDOM Royal Marsden NHS Foundation Trust 30 5,000 SOUTH KOREA Seoul National University -
NIH Public Access Author Manuscript Nat Genet
NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2013 October 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Nat Genet. 2013 April ; 45(4): 371–384e2. doi:10.1038/ng.2566. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Stig E Bojesen1,2,*, Karen A Pooley3,*, Sharon E Johnatty4,*, Jonathan Beesley4,*, Kyriaki Michailidou3,*, Jonathan P Tyrer5,*, Stacey L Edwards6, Hilda A Pickett7,8, Howard C Shen9, Chanel E Smart10, Kristine M Hillman6, Phuong L Mai11, Kate Lawrenson9, Michael D Stutz7,8, Yi Lu4, Rod Karevan9, Nicholas Woods12, Rebecca L Johnston10, Juliet D French6, Xiaoqing Chen4, Maren Weischer1,2, Sune F Nielsen1,2, Melanie J Maranian5, Maya Ghoussaini5, Shahana Ahmed5, Caroline Baynes5, Manjeet K Bolla3, Qin Wang3, Joe Dennis3, Lesley McGuffog3, Daniel Barrowdale3, Andrew Lee3, Sue Healey4, Michael Lush3, Daniel C Tessier13,14, Daniel Vincent13,14, Françis Bacot13,14, Study Group members15, Ignace Vergote16,17, Sandrina Lambrechts16,17, Evelyn Despierre16,17, Harvey A Risch18, Anna González-Neira19, Mary Anne Rossing20,21, Guillermo Pita19, Jennifer A Doherty22, Nuria Álvarez19, Melissa C Larson23, Brooke L Fridley23, Nils Schoof24, Jenny Chang- Claude25, Mine S Cicek26, Julian Peto27, Kimberly R Kalli28, Annegien Broeks29, Sebastian M Armasu23, Marjanka K Schmidt29,30, Linde M Braaf29, Boris Winterhoff31, Heli Nevanlinna32, Gottfried E Konecny33, Diether Lambrechts34,35, -
Biographical References for Nobel Laureates
Dr. John Andraos, http://www.careerchem.com/NAMED/Nobel-Biographies.pdf 1 BIOGRAPHICAL AND OBITUARY REFERENCES FOR NOBEL LAUREATES IN SCIENCE © Dr. John Andraos, 2004 - 2021 Department of Chemistry, York University 4700 Keele Street, Toronto, ONTARIO M3J 1P3, CANADA For suggestions, corrections, additional information, and comments please send e-mails to [email protected] http://www.chem.yorku.ca/NAMED/ CHEMISTRY NOBEL CHEMISTS Agre, Peter C. Alder, Kurt Günzl, M.; Günzl, W. Angew. Chem. 1960, 72, 219 Ihde, A.J. in Gillispie, Charles Coulston (ed.) Dictionary of Scientific Biography, Charles Scribner & Sons: New York 1981, Vol. 1, p. 105 Walters, L.R. in James, Laylin K. (ed.), Nobel Laureates in Chemistry 1901 - 1992, American Chemical Society: Washington, DC, 1993, p. 328 Sauer, J. Chem. Ber. 1970, 103, XI Altman, Sidney Lerman, L.S. in James, Laylin K. (ed.), Nobel Laureates in Chemistry 1901 - 1992, American Chemical Society: Washington, DC, 1993, p. 737 Anfinsen, Christian B. Husic, H.D. in James, Laylin K. (ed.), Nobel Laureates in Chemistry 1901 - 1992, American Chemical Society: Washington, DC, 1993, p. 532 Anfinsen, C.B. The Molecular Basis of Evolution, Wiley: New York, 1959 Arrhenius, Svante J.W. Proc. Roy. Soc. London 1928, 119A, ix-xix Farber, Eduard (ed.), Great Chemists, Interscience Publishers: New York, 1961 Riesenfeld, E.H., Chem. Ber. 1930, 63A, 1 Daintith, J.; Mitchell, S.; Tootill, E.; Gjersten, D., Biographical Encyclopedia of Scientists, Institute of Physics Publishing: Bristol, UK, 1994 Fleck, G. in James, Laylin K. (ed.), Nobel Laureates in Chemistry 1901 - 1992, American Chemical Society: Washington, DC, 1993, p. 15 Lorenz, R., Angew. -
Allergy – What’S in a Name?
HISTORY OF ENT Allergy – what’s in a name? BY KATHERINE CONROY llergy is defined as an “abnormal immune reaction to an ordinarily harmless substance” [1], however Athe meaning of the word has taken many forms since its introduction in 1906 by Austrian Paediatrician and Immunologist, Clemens von Pirquet [2]. Combining his observations on the paediatric wards, where infectious diseases, vaccinations and diphtheria serum sickness were commonplace, and his knowledge of immune reactions in the laboratory, von Pirquet devised the term ‘allergy’, roughly translating as ‘different reaction’ in Greek. It grouped together illnesses such as asthma, hay fever and eczema, and placed them on the same spectrum as acquired immunity from vaccinations and reactions to therapeutic toxins. His conclusions were extrapolated by Charles Mantoux to develop his tuberculin test two years later. Unfortunately, this theory linking Clemens von Pirquet with a patient. Image courtesy of Wellcome Collection - https://wellcomecollection.org/works/yd78ffbn immunity and hypersensitivity, and von Piquet’s subsequent inference that antibodies could be both protective and also include morbidity – as governments References 1. AAAAI. The American Academy of Allergy, Asthma harmful, was dismissed by many of his peers, realised the economic cost of chronic illness. Allergy became a clinical specialty in its & Immunology. www.aaaai.org/conditions-and- who instead supported French Physiologist, treatments/conditions-dictionary/allergy Last Charles Richet. Richet’s work on reinjection own right, with dedicated clinics, journals accessed October 2020. of dogs with sea anemone toxins showed and professional organisations in the 2. Jackson M. Allergy, The History of a Modern Malady. that a small, second dose could induce a interwar years. -
Dissociation and the Unconscious Mind: Nineteenth-Century Perspectives on Mediumship
Journal of Scientifi c Exploration, Vol. 34, No. 3, pp. 537–596, 2020 0892-3310/20 HISTORICAL PERSPECTIVE Dissociation and the Unconscious Mind: Nineteenth-Century Perspectives on Mediumship C!"#$% S. A#&!"!'$ Parapsychology Foundation [email protected] Submitted December 18, 2019; Accepted March 21, 2020; Published September 15, 2020 https://doi.org/10.31275/20201735 Creative Commons License CC-BY-NC Abstract—There is a long history of discussions of mediumship as related to dissociation and the unconscious mind during the nineteenth century. A! er an overview of relevant ideas and observations from the mesmeric, hypnosis, and spiritualistic literatures, I focus on the writings of Jules Baillarger, Alfred Binet, Paul Blocq, Théodore Flournoy, Jules Héricourt, William James, Pierre Janet, Ambroise August Liébeault, Frederic W. H. Myers, Julian Ochorowicz, Charles Richet, Hippolyte Taine, Paul Tascher, and Edouard von Hartmann. While some of their ideas reduced mediumship solely to intra-psychic processes, others considered as well veridical phenomena. The speculations of these individuals, involving personation, and di" erent memory states, were part of a general interest in the unconscious mind, and in automatisms, hysteria, and hypnosis during the period in question. Similar ideas continued into the twentieth century. Keywords: mediumship; dissociation; secondary personalities; Frederic W. H. Myers; Théodore Flournoy; Pierre Janet INTRODUCTION Dissociation, a process involving the disconnection of a sense of identity, physical sensations, and memory from conscious experience, has been related to mediumship due to the latter’s sensory and motor automatism and changes of identity. In recent years there have been some conceptual discussions of dissociation and mediumship (e.g., Maraldi et al., 2019) as well as empirical studies exploring their 538 Carlos S. -
Balcomk41251.Pdf (558.9Kb)
Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr. -
Centenary of the Death of Elie Metchnikoff: a Visionary and an Outstanding Team Leader
+ MODEL Microbes and Infection xx (2016) 1e18 www.elsevier.com/locate/micinf Review Centenary of the death of Elie Metchnikoff: a visionary and an outstanding team leader Jean-Marc Cavaillon a,*, Sandra Legout b a Unit Cytokines & Inflammation, Institut Pasteur, 28 Rue Dr. Roux, 75015 Paris, France b Centre de Ressources en Information Scientifique, Institut Pasteur, 28 Rue Dr. Roux, 75015 Paris, France Received 22 April 2016; accepted 26 May 2016 Available online ▪▪▪ Abstract Elie Metchnikoff passed away on July 15th, 1916. He is considered to be the father of phagocytes, cellular innate immunity, probiotics, and gerontology. In all of these fields, he was a visionary. To achieve such a notability and produce so many masterpieces, Metchnikoff used more than 30 animal species to support his findings, and his pasteurian laboratory published more than 200 papers in the Annales de l’Institut Pasteur. As a wonderful team leader and a great mentor, during his 28 years at Institut Pasteur, he welcomed and supervised more than 100 young trainees. Trained as an embryologist, he contributed to the birth of immunology and to the understanding of physiology and pathology. Indeed, Metchnikoff and his team investigated inflammation in guinea pigs, rats, frogs; studied infectious diseases in monkeys, caimans, geese; investigated aging in parrots, dogs, humans; proposed hypotheses to understand age-associated senility using rabbits and humans; developed germ free tadpoles, flies, chicks; studied the gut flora in bats, horses, birds, humans; and popularized the use of probiotics as a tool to delay the deleterious effects of toxic compounds derived from putrefactive gut bacteria. -
Guest Editorial 1 Guest Editorial
Indian JJ PhysiolPhysiol PharmacolPharmacol 2012; 2012; 56(1) 56(1) : 1–6 Guest Editorial 1 Guest Editorial IMMUNOLOGY AND NOBEL PRIZE : A LOVE STORY Several breakthroughs revealing the way in which our bodies protect us against microscopic threats of almost any description have been duly acknowledged by the Nobel Prizes in Physiology or Medicine. Interestingly, Nobel Prizes in Physiology or Medicine including the latest one, for the year 2011, has been awarded for twelve times to the field of Immunology. The story began in 1901 with the very first Nobel Prize in Physiology or Medicine - it was awarded to Emil Von Behring for his pioneering work which resulted in the discovery of antitoxins, later termed as antibodies. Working with Shibasaburo Kitasato, Von Behring found that when animals were injected with tiny doses of weakened forms of tetanus or diphtheria bacteria, their blood extracts contained chemicals released in response, which rendered the pathogens’ toxins harmless. Naming these chemical agents ‘antitoxins’, Von Behring and Erich Wernicke showed that transferring antitoxin-containing blood serum into animals infected with the fully virulent versions of diphtheria bacteria cured the recipients of any symptoms, and prevented death. This was found to be true for humans also; and thus Von Behring’s method of treatment – passive serum therapy – became an essential remedy for diphtheria, saving many thousands of lives every year. Shortly after this, the very first explanation about the mechanisms of immune system’s functioning was proposed which paved way for extensive research in immunology till today. Paul Ehrlich had hit upon the key concept of how antibodies seek and neutralize the toxic actions of bacteria, while Ilya Mechnikov had discovered that certain body cells could destroy pathogens by simply engulfing or “eating” them. -
The Fascinating Germ Theories on Cancer Pathogenesis G
JBUON 2014; 19(1): 319-323 ISSN: 1107-0625, online ISSN: 2241-6293 • www.jbuon.com E-mail: [email protected] HISTORY OF ONCOLOGY The fascinating germ theories on cancer pathogenesis G. Tsoucalas1, K. Laios1, M. Karamanou1, V. Gennimata2, G. Androutsos1 1Department of History of Medicine, Medical School, University of Athens, Athens; 2Department of Microbiology, Medical School, University of Athens, Athens, Greece Summary bel Prize in 1926 that was attributed to the Danish scientist Johannes Fibiger for his work on the nematode Spiroptera as a For more than 100 years, the germ theory of cancer, pro- causative agent in cancer. Even if those theories were the result posing that microorganisms were at the origin of the disease, of fantasy and misinterpretation, they paved the way for the dominated medicine. Several eminent scientists like Etienne scientific research in oncology. Burnet, Mikhail Stepanovich Voronin, Charles-Louis Mal- assez, and Francis-Peyton Rous argued on the pathogenesis presenting their theories that implicated cocci, fungi and par- Key words: carcinogenesis, germ theories, Johannes Fibiger, asites. The impact of these theories was culminated by the No- parasitic theory Introduction transmission was explained. It is long discussed for cancer that heredity is a legend that will vanish Apart from the exogenous, strange for today’s when contagion will be proved” [1]. medical world, misconceptions about cancer (can- cer villages, cancer houses, cancer countries, can- The germs of cancer: coccus and fungi cer races), the microbial theory of cancer held a significant place in the scientific community dur- Several scientists believed that cancerous ing the second half of the 19th century, similarly to germ had a preference for wetlands and could be tuberculosis during the previous decades. -
Emil Von Behring (1854–1917) the German Bacteriologist
Emil von Behring (1854–1917) The German bacteriologist and Nobel Prize winner Emil von Behring ranks among the most important medical scientists. Behring was born in Hansdorff, West Prussia, as the son of a teacher in 1854. He grew up in narrow circumstances among eleven brothers and sisters. His desire to study medicine could only be realized by fulfilling the obligation to work as an military doctor for a longer period of time. Between 1874 and 1878 he studied medicine at the Akademie für das militärärztliche Bildungswesen in Berlin. In 1890, after having published his paper Ueber das Zustandekommen der Diphtherie- Immunität und der Tetanus-Immunität bei Thieren, he captured his scientific breakthrough. While having worked as Robert Koch’s scientific assistant at the Berlin Hygienic Institute he had been able to show – together with his Japanese colleague Shibasaburo Kitasato (1852–1931) – via experimentation on animal that it was possible to neutralize pathogenic germs by giving „antitoxins“. Behring demonstrated that the antitoxic qualities of blood are not seated in cells, but in the cell-free serum. Antitoxins recovered of human convalenscents or laboratorty animals, prove themselves as life-saving when being applied to diseased humans. At last – due to Behring’s discovery of the body’s own immune defence and due to his development of serotherapy against diphtheria and tetanus – a remedy existed which was able to combat via antitoxin those infectious diseases which had already broken out. Having developped a serum therapy against diphtheria and tetanus Behring won the first Nobel Prize in Medicine in 1901. Six years before, in 1895, he had become professor of Hygienics within the Faculty of Medicine at the University of Marburg, a position he would hold for the rest of his life. -
Timeline of Immunology
TIMELINE OF IMMUNOLOGY 1549 – The earliest account of inoculation of smallpox (variolation) occurs in Wan Quan's (1499–1582) 1718 – Smallpox inoculation in Ottoman Empire realized by West. Lady Mary Wortley Montagu, the wife of the British ambassador to Constantinople, observed the positive effects of variolation on the native population and had the technique performed on her own children. 1796 – First demonstration of smallpox vaccination (Edward Jenner) 1837 – Description of the role of microbes in putrefaction and fermentation (Theodore Schwann) 1838 – Confirmation of the role of yeast in fermentation of sugar to alcohol (Charles Cagniard-Latour) 1840 – Proposal of the germ theory of disease (Jakob Henle) 1850 – Demonstration of the contagious nature of puerperal fever (childbed fever) (Ignaz Semmelweis) 1857–1870 – Confirmation of the role of microbes in fermentation (Louis Pasteur) 1862 – Phagocytosis (Ernst Haeckel) 1867 – Aseptic practice in surgery using carbolic acid (Joseph Lister) 1876 – Demonstration that microbes can cause disease-anthrax (Robert Koch) 1877 – Mast cells (Paul Ehrlich) 1878 – Confirmation and popularization of the germ theory of disease (Louis Pasteur) 1880 – 1881 -Theory that bacterial virulence could be attenuated by culture in vitro and used as vaccines. Proposed that live attenuated microbes produced immunity by depleting host of vital trace nutrients. Used to make chicken cholera and anthrax "vaccines" (Louis Pasteur) 1883 – 1905 – Cellular theory of immunity via phagocytosis by macrophages and microphages (polymorhonuclear leukocytes) (Elie Metchnikoff) 1885 – Introduction of concept of a "therapeutic vaccination". Report of a live "attenuated" vaccine for rabies (Louis Pasteur and Pierre Paul Émile Roux). 1888 – Identification of bacterial toxins (diphtheria bacillus) (Pierre Roux and Alexandre Yersin) 1888 – Bactericidal action of blood (George Nuttall) 1890 – Demonstration of antibody activity against diphtheria and tetanus toxins.